Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. Continue Reading
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
Novo Surges 6% After Walloping Expectations On The Back Of Its GLP-1 Drugs
